Michael Schaengold, Melissa Prusock, and Danielle Muenzfeld co-authored an article in The Government Contractor titled “FEATURE COMMENT: The FY 2020 National Defense Authorization Act’s Substantial Impact On Federal
Continue Reading The FY 2020 National Defense Authorization Act’s Substantial Impact On Federal Procurement Law

A newly approved Bill could significantly increase disclosure requirements for Israelis invested in or operating business in the U.S. The Corporate Transparency Act of 2019 would require that the identities
Continue Reading U.S. House Passes Bill That Would Require Disclosure of Beneficial Owners of U.S. Corporations and Limited Liability Companies

The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private
Continue Reading 2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors

Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration
Continue Reading Does Section 1782 Apply to Discovery in Private International Commercial Arbitration Proceedings?